Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings
- 93.061 -- Innovations in Applied Public Health Research
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: March 9, 2025
- Closed: November 4, 2024
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Award details
- Expected project funding: $7,500,000
- Expected awards: 8
Award min.
$0
Award max.
$500,000
- Funding opportunity number:RFA-TS-25-036
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: August 1, 2024
- Archive date: March 9, 2025
- Version: 4
Summary
Jump to documentsThe Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to...
support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.
Eligibility
Government
- Federally recognized Native American tribal governments
- Public and Indian housing authorities
- City or township governments
- Special district governments
- County governments
- State governments
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Miscellaneous
- Unrestricted
- Other
Additional information on eligibility
See Section III. Eligibility Information.
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-TS-25-036_Questions_and_Answers_20241009.docx | RFA-TS-25-036 Questions and Answers_20241009.docx | Oct 9, 2024 10:55 PM UTC |
| RFA-TS-25-036_20241009.pdf | RFA-TS-25-036_20241009.pdf | Oct 9, 2024 10:51 PM UTC |
| RFA-TS-25-036_Questions_and_Answers.docx | RFA-TS-25-036 Questions and Answers.docx | Oct 7, 2024 07:00 PM UTC |
| RFA-TS-25-036_20240830.pdf | RFA-TS-25-036_20240830.pdf | Aug 31, 2024 12:53 AM UTC |
| RFA-TS-25-036.pdf | RFA-TS-25-036.pdf | Aug 1, 2024 07:32 PM UTC |
Agency contact information
Email: ncipc_erpo@cdc.gov
ncipc_erpo@cdc.gov
Candis M. Hunter, PhD, MSPH, REHS
ncipc_erpo@cdc.gov
Link to additional information
No additional information is available
